Syon Capital’s Core Laboratories CLB Stock Holding History

Syon Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,757	Closed	-$186K	–	598
2024 Q4	$186K	Buy	+10,757	New	+$208K	0.02%	526

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Syon Capital's CLB Position: Q1 2025 in Review

Syon Capital sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 10,757 shares — an estimated $186K sold.

Syon Capital first reported a position in CLB in Q4 2024 and held it in 1 quarter. The position peaked at $186K in Q4 2024. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

Syon Capital reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
Syon Capital sold 10,757 Core Laboratories shares in Q1 2025, an estimated $186K.
Syon Capital first reported a position in Core Laboratories in Q4 2024 and held it in 1 quarter.
Syon Capital's Core Laboratories position peaked at $186K in Q4 2024.
195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.